Cargando…
Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009
PURPOSE: The increasing prevalence of antimicrobial resistant bacteria has become a serious worldwide problem. The aim of this study was to analyze antimicrobial resistance data generated in 2009 by hospitals and commercial laboratories participating in the Korean Nationwide Surveillance of Antimicr...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159946/ https://www.ncbi.nlm.nih.gov/pubmed/21786445 http://dx.doi.org/10.3349/ymj.2011.52.5.793 |
_version_ | 1782210498917302272 |
---|---|
author | Lee, Kyungwon Kim, Mi-Na Kim, Jae-Seok Hong, Hye Lim Kang, Jung Oak Shin, Jong Hee Park, Yeon-Joon Yong, Dongeun Jeong, Seok Hoon Chong, Yunsop |
author_facet | Lee, Kyungwon Kim, Mi-Na Kim, Jae-Seok Hong, Hye Lim Kang, Jung Oak Shin, Jong Hee Park, Yeon-Joon Yong, Dongeun Jeong, Seok Hoon Chong, Yunsop |
author_sort | Lee, Kyungwon |
collection | PubMed |
description | PURPOSE: The increasing prevalence of antimicrobial resistant bacteria has become a serious worldwide problem. The aim of this study was to analyze antimicrobial resistance data generated in 2009 by hospitals and commercial laboratories participating in the Korean Nationwide Surveillance of Antimicrobial Resistance program. MATERIALS AND METHODS: Susceptibility data were collected from 24 hospitals and two commercial laboratories. In the analysis, resistance did not include intermediate susceptibility. Duplicate isolates were excluded from the analysis of hospital isolates, but not from the commercial laboratory isolates. RESULTS: Among the hospital isolates, methicillin-resistant Staphylococcus aureus, penicillin G-non-susceptible Streptococcus pneumoniae based on meningitis breakpoint, and ampicillin-resistant Enterococcus faecium remained highly prevalent. The proportion of vancomycin-resistant E. faecium gradually increased to 29%. Ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae increased to 17% and 33%, respectively, and fluoroquinolone-resistant K. pneumoniae, Acinetobacter spp. and Pseudomonas aeruginosa increased to 33%, 67% and 39%, respectively. Amikacin-resistant Acinetobacter spp. increased to 48%. Imipenem-resistant Acinetobacter spp. and P. aeruginosa increased to 51% and 26%, respectively. Higher resistance rates were observed in intensive care unit (ICU) isolates than in non-ICU isolates among the isolates from hospitals. Resistance rates were higher in hospital isolates than in clinic isolates among the isolates from commercial laboratories. CONCLUSION: Among the hospital isolates, ceftazidime-resistant K. pneumoniae and fluoroquinolone-resistant K. pneumoniae, Acinetobacter spp., and P. aeruginosa further increased. The increase in imipenem resistance was slight in P. aeruginosa, but drastic in Acinetobacter spp. The problematic antimicrobial-organism combinations were much more prevalent among ICU isolates. |
format | Online Article Text |
id | pubmed-3159946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Yonsei University College of Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-31599462011-09-07 Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009 Lee, Kyungwon Kim, Mi-Na Kim, Jae-Seok Hong, Hye Lim Kang, Jung Oak Shin, Jong Hee Park, Yeon-Joon Yong, Dongeun Jeong, Seok Hoon Chong, Yunsop Yonsei Med J Original Article PURPOSE: The increasing prevalence of antimicrobial resistant bacteria has become a serious worldwide problem. The aim of this study was to analyze antimicrobial resistance data generated in 2009 by hospitals and commercial laboratories participating in the Korean Nationwide Surveillance of Antimicrobial Resistance program. MATERIALS AND METHODS: Susceptibility data were collected from 24 hospitals and two commercial laboratories. In the analysis, resistance did not include intermediate susceptibility. Duplicate isolates were excluded from the analysis of hospital isolates, but not from the commercial laboratory isolates. RESULTS: Among the hospital isolates, methicillin-resistant Staphylococcus aureus, penicillin G-non-susceptible Streptococcus pneumoniae based on meningitis breakpoint, and ampicillin-resistant Enterococcus faecium remained highly prevalent. The proportion of vancomycin-resistant E. faecium gradually increased to 29%. Ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae increased to 17% and 33%, respectively, and fluoroquinolone-resistant K. pneumoniae, Acinetobacter spp. and Pseudomonas aeruginosa increased to 33%, 67% and 39%, respectively. Amikacin-resistant Acinetobacter spp. increased to 48%. Imipenem-resistant Acinetobacter spp. and P. aeruginosa increased to 51% and 26%, respectively. Higher resistance rates were observed in intensive care unit (ICU) isolates than in non-ICU isolates among the isolates from hospitals. Resistance rates were higher in hospital isolates than in clinic isolates among the isolates from commercial laboratories. CONCLUSION: Among the hospital isolates, ceftazidime-resistant K. pneumoniae and fluoroquinolone-resistant K. pneumoniae, Acinetobacter spp., and P. aeruginosa further increased. The increase in imipenem resistance was slight in P. aeruginosa, but drastic in Acinetobacter spp. The problematic antimicrobial-organism combinations were much more prevalent among ICU isolates. Yonsei University College of Medicine 2011-09-01 2011-07-18 /pmc/articles/PMC3159946/ /pubmed/21786445 http://dx.doi.org/10.3349/ymj.2011.52.5.793 Text en © Copyright: Yonsei University College of Medicine 2011 http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Lee, Kyungwon Kim, Mi-Na Kim, Jae-Seok Hong, Hye Lim Kang, Jung Oak Shin, Jong Hee Park, Yeon-Joon Yong, Dongeun Jeong, Seok Hoon Chong, Yunsop Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009 |
title | Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009 |
title_full | Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009 |
title_fullStr | Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009 |
title_full_unstemmed | Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009 |
title_short | Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009 |
title_sort | further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of acinetobacter spp. and p. aeruginosa in korea: konsar study 2009 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159946/ https://www.ncbi.nlm.nih.gov/pubmed/21786445 http://dx.doi.org/10.3349/ymj.2011.52.5.793 |
work_keys_str_mv | AT leekyungwon furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009 AT kimmina furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009 AT kimjaeseok furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009 AT honghyelim furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009 AT kangjungoak furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009 AT shinjonghee furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009 AT parkyeonjoon furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009 AT yongdongeun furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009 AT jeongseokhoon furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009 AT chongyunsop furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009 AT furtherincreasesincarbapenemamikacinandfluoroquinoloneresistantisolatesofacinetobactersppandpaeruginosainkoreakonsarstudy2009 |